113 related articles for article (PubMed ID: 4344014)
1. An effect of insulin on the adenosine 3':5'-cyclic monophosphate phosphodiesterase and guanosine 3':5'-cyclic monophosphate phosphodiesterase activities in the perfused Langendorff and working hearts of normal and diabetic rats.
Das I; Chain EB
Biochem J; 1972 Jul; 128(3):95P-96P. PubMed ID: 4344014
[No Abstract] [Full Text] [Related]
2. Effect of diabetes and insulin on the rat heart adenyl cyclase, cyclic AMP phosphodiesterase and cyclic AMP.
Das I
Horm Metab Res; 1973 Sep; 5(5):330-3. PubMed ID: 4358423
[No Abstract] [Full Text] [Related]
3. Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesterase.
Harris DN; Chasin M; Phillips MB; Goldenberg H; Samaniego S; Hess SM
Biochem Pharmacol; 1973 Jan; 22(2):221-8. PubMed ID: 4357795
[No Abstract] [Full Text] [Related]
4. Effect of insulin and growth hormone on rat liver cyclic nucleotide phosphodiesterase.
Thompson WJ; Little SA; Williams RH
Biochemistry; 1973 May; 12(10):1889-94. PubMed ID: 4350103
[No Abstract] [Full Text] [Related]
5. Cyclic nucleotide phosphodiesterase activity in the plasma and erythrocytes of normal and diabetic rats.
Hemington JG; Chenoweth M; Dunn A
Biochim Biophys Acta; 1973 Apr; 304(2):552-9. PubMed ID: 4351080
[No Abstract] [Full Text] [Related]
6. Regulation of cyclic nucleotide phosphodiesterase.
Appleman MM; Terasaki WL
Adv Cyclic Nucleotide Res; 1975; 5():153-62. PubMed ID: 165663
[No Abstract] [Full Text] [Related]
7. Changes in activity of phosphodiesterase of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate during larval development of locust Schistocerca gregaria (Forsk.) (Orthoptera).
Bielimska M; Piechowska MJ
Bull Acad Pol Sci Biol; 1975; 23(1):1-5. PubMed ID: 165864
[No Abstract] [Full Text] [Related]
8. [Study of the effect of adenosine cyclic 3'-5'-monophosphate (3'-5'-AMPc) and cyclic 3'-5'-phosphodiesterase (3'-5'-FDEc) on the adipose tissue of normal, diabetic and obese patients].
Yáñez Polo MA; Soriguer Escofet FC; Lissen Otero E; Causse Prado M; Perez Cano R; Melero Bellido M; Muñóz-González J
Rev Clin Esp; 1972 Nov; 127(3):765-70. PubMed ID: 4346995
[No Abstract] [Full Text] [Related]
9. Cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities are under separate genetic control.
Russell TR; Pastan IH
J Biol Chem; 1974 Dec; 249(24):7764-9. PubMed ID: 4372218
[No Abstract] [Full Text] [Related]
10. The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release. Properties of islet-cell adenosine 3':5'-cyclic monophosphate phosphodiesterase.
Sams DJ; Montague W
Biochem J; 1972 Oct; 129(4):945-52. PubMed ID: 4347900
[TBL] [Abstract][Full Text] [Related]
11. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
Cubeddu L; Barnes E; Weiner N
J Pharmacol Exp Ther; 1975 Apr; 193(1):105-27. PubMed ID: 166157
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphates VI. Cyclophosphates as substrates and effectors of phosphodiesterase.
Michal G; Mühlegger K; Nelboeck M; Thiessen C; Weimann G
Pharmacol Res Commun; 1974 Jun; 6(3):203-52. PubMed ID: 4372643
[No Abstract] [Full Text] [Related]
13. Regulation of nucleoside cyclic 3':5'-monophosphate phosphodiesterase activity from rat brain by a modulator and Ca2+.
Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K
Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3526-30. PubMed ID: 4357877
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
[No Abstract] [Full Text] [Related]
15. Bovine heart protein activator of cyclic nucleotide phosphodiesterase.
Wang JH; Teo TS; Ho HC; Stevens FC
Adv Cyclic Nucleotide Res; 1975; 5():179-94. PubMed ID: 165665
[No Abstract] [Full Text] [Related]
16. Studies on 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine(BL 191). I. Cyclic 3',5'-nucleotide phosphodiesterase (PDE) and the inhibitory effect of BL 191 on PDE in rat brain and heart.
Hayashi S; Ozawa H
Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):587-93. PubMed ID: 4371104
[No Abstract] [Full Text] [Related]
17. Effect of insulin and lipolytic hormones on cyclic AMP phosphodieterase activity in normal and diabetic rat adipose tissue.
Solomon SS
Endocrinology; 1975 Jun; 96(6):1366-73. PubMed ID: 165058
[TBL] [Abstract][Full Text] [Related]
18. The in vitro 14 C-cyclic AMP production by normal human adipose tissue in response to some hormones and in uncontrolled and controlled diabetic adipose tissue.
Kissebah AH; Fraser TR
Horm Metab Res; 1972 Mar; 4(2):72-7. PubMed ID: 4337575
[No Abstract] [Full Text] [Related]
19. Cyclic nucleotide phosphodiesterase activity in cardiac and vascular smooth muscle of the spontaneously hypertensive rat.
Taylor JE; Shirachi DY
Proc West Pharmacol Soc; 1977; 20():307-10. PubMed ID: 197543
[No Abstract] [Full Text] [Related]
20. The effect of adenylate cyclase inhibitor (ACI) on guanylate cyclase, phosphodiesterase and other enzymes in heart.
Lehotay DC; Levey GS; Vesely DL; Bornet EP; Ray MV; Entman ML; Schwartz A
J Cyclic Nucleotide Res; 1977 Feb; 3(1):55-65. PubMed ID: 14979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
